SPI-1005 Treatment in Moderate COVID-19 Patients
Clinical trial NCT04484025 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT04484025
- Sponsor
- Sound Pharmaceuticals, Incorporated
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-12
- Primary completion
- 2023-12-31
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.